6533b7d9fe1ef96bd126bfc5

RESEARCH PRODUCT

630 SERUM BLYS/BAFF LEVELS IN ACUTE HEPATITIS C PREDICT CLINICAL OUTCOME

A. IacòR. Di StefanoA. CiaccioF. D’antoniV. Di MarcoGiuseppe TarantinoA. LicataP.l. AlmasioAntonio CraxìF. BarbariaS. Petta

subject

Hepatologybusiness.industryImmunologyMedicineAcute hepatitis CbusinessB-cell activating factorhttps://doi.org/10.1016/s0168-8278(08)60632-7